News Mission Therapeutics raises £60m to advance novel ‘DUB’ drug platform Andrew McConaghie Mission Therapeutics, Prof Steve Jackson, UK biotech 0 Comment UK biotech company Mission Therapeutics has raised £60 million to invest into its drug discovery and development programme. Share X Mission Therapeutics raises £60m to advance novel ‘DUB’ drug platform https://pharmaphorum.com/news/mission-therapeutics-raises-60m-to-advance-novel-dub-drug-platform/
Mission Therapeutics, Prof Steve Jackson, UK biotech
0 Comment
